PAREXEL INTERNATIONAL TO PRESENT AT 25TH ANNUAL JPMORGAN HEALTHCARE CONFERENCE
BOSTON, MA, January 4, 2007 — PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the 25th Annual JPMorgan Healthcare Conference at The Westin St. Francis in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a formal presentation on PAREXEL at 3:00 pm PT on Wednesday, January 10, 2007.
A live webcast of this presentation will be available at https://events.jpmorgan.com. Click on the JPMorgan Healthcare Conference link to register. Upon registering, the Conference Welcome Page will appear, click on the Live Webcast link to the left and then click on PAREXEL. The webcast will be available on demand approximately 24 hours after the live presentation and will be available for three months. If you have any difficulties with the webcast, please email email@example.com.
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales. The technology portfolio includes web-based portal solutions and tracking tools, Interactive Voice Response Systems (IVRS), Clinical Trial Management Systems (CTMS), electronic diary and investigator database solutions. Perceptive also offers advanced medical diagnostics services to assess rapidly and objectively the safety and efficacy of new drugs, biologics, and medical devices in clinical trials. PAREXEL’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 54 locations throughout 40 countries around the world, and has 6,000 full-time employees.
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.